BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng Z, Wei-Qi J, Jin D. New insights on sorafenib resistance in liver cancer with correlation of individualized therapy. Biochim Biophys Acta Rev Cancer 2020;1874:188382. [PMID: 32522600 DOI: 10.1016/j.bbcan.2020.188382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. World J Clin Cases 2022; 10(11): 3321-3333 [DOI: 10.12998/wjcc.v10.i11.3321] [Reference Citation Analysis]
2 Wang B, Sun L, Wen M, Tan Y, Almalki WH, Katouah H, Kazmi I, Afzal O, Altamimi ASA, Al-Abbasi FA, Alrobaian M, Alharbi KS, Alenezi SK, Alghaith AF, Beg S, Rahman M. Nano lipidic carriers for codelivery of sorafenib and ganoderic acid for enhanced synergistic antitumor efficacy against hepatocellular carcinoma. Saudi Pharm J 2021;29:843-56. [PMID: 34408545 DOI: 10.1016/j.jsps.2021.06.006] [Reference Citation Analysis]
3 Hu J, Chang Y, Hsieh C, Huang S. The Synergistic Cytotoxic Effects of GW5074 and Sorafenib by Impacting Mitochondrial Functions in Human Colorectal Cancer Cell Lines. Front Oncol 2022;12:925653. [DOI: 10.3389/fonc.2022.925653] [Reference Citation Analysis]
4 Shi Y, Liu JB, Deng J, Zou DZ, Wu JJ, Cao YH, Yin J, Ma YS, Da F, Li W. The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma. Hereditas 2021;158:44. [PMID: 34758879 DOI: 10.1186/s41065-021-00208-7] [Reference Citation Analysis]
5 Zhang G, Huang X, Xiu H, Sun Y, Chen J, Cheng G, Song Z, Peng Y, Shen Y, Wang J, Cai Z. Extracellular vesicles: Natural liver-accumulating drug delivery vehicles for the treatment of liver diseases. J Extracell Vesicles 2020;10:e12030. [PMID: 33335695 DOI: 10.1002/jev2.12030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Yang X, Zheng Y, Liu L, Huang J, Wang F, Zhang J. Progress on the study of the anticancer effects of artesunate. Oncol Lett 2021;22:750. [PMID: 34539854 DOI: 10.3892/ol.2021.13011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang S, Yang S, Zhang H, Hua H, Kong Q, Wang J, Jiang Y. Targeting Na+ /K+ -ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma. Br J Pharmacol 2021. [PMID: 34233013 DOI: 10.1111/bph.15616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Y, Tan Y, Liu S, Yin H, Duan J, Fan L, Zhao X, Jiang B. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis. Toxicol Mech Methods 2022;:1-9. [PMID: 35592903 DOI: 10.1080/15376516.2022.2075297] [Reference Citation Analysis]
9 Ning D, Chen J, Du P, Liu Q, Cheng Q, Li X, Zhang B, Chen X, Jiang L. The crosstalk network of XIST/miR-424-5p/OGT mediates RAF1 glycosylation and participates in the progression of liver cancer. Liver Int 2021;41:1933-44. [PMID: 33909326 DOI: 10.1111/liv.14904] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Zhao X, Sun X, Huang W, Chen R, Chen K, Nie L, Fang C. A microenvironment-responsive FePt probes for imaging-guided Fenton-enhanced radiotherapy of hepatocellular carcinoma. J Nanobiotechnology 2022;20:100. [PMID: 35241082 DOI: 10.1186/s12951-022-01305-z] [Reference Citation Analysis]
11 Zhen Z, Shen Z, Sun P. Downregulation of Low-density lipoprotein receptor-related protein 1B (LRP1B) inhibits the progression of hepatocellular carcinoma cells by activating the endoplasmic reticulum stress signaling pathway. Bioengineered 2022;13:9467-81. [PMID: 35389768 DOI: 10.1080/21655979.2022.2060778] [Reference Citation Analysis]
12 He Y, Luo Y, Huang L, Zhang D, Wang X, Ji J, Liang S. New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Pharmacol Res 2021;170:105732. [PMID: 34139345 DOI: 10.1016/j.phrs.2021.105732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chen S, Chen H, Zhang Y, Li W. Efficacy and Safety of Cellular Immunotherapy by Local Infusion for Liver Tumor: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:772509. [DOI: 10.3389/fonc.2022.772509] [Reference Citation Analysis]